Company Aptamer Sciences Inc

Equities

A291650

KR7291650000

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 03:30:00 10/05/2024 am IST			5-day change	1st Jan Change
2,770 ^KRW	-1.95%		-2.29%	-23.16%

26/03	Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201	CI
2022	Aptamer Sciences Inc announced that it has received KRW 16.5 billion in funding from a group of investors	CI

Aptamer Sciences Inc is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The Company provides services include aptamer synthesis and aptamer discovery. The Company also develops biopharmaceuticals such as insulin substitutes, insulin sensitizers, and liver cancer drugs. In addition, the Company also produces lung cancer diagnostic kits.

KRW in Million	2022	Weight	2023	Weight	Delta
Synthetic Services 88.5 %	319	89.1 %	215	88.5 %	-32.63%
Excavation Service 11.5 %	36	10.1 %	28	11.5 %	-22.23%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	358	100.0 %	243	100.0 %	-32.12%

Managers	Title	Age	Since
Dong-Il Han CEO	Chief Executive Officer	-	01/11/01
Sung-Ho Ryu CTO	Chief Tech/Sci/R&D Officer	-	01/11/01
Young-Ki Yoon BRD	Director/Board Member	54	01/19/01
Se-Hyun Oh AUD	Comptroller/Controller/Auditor	64	01/18/01

Members of the board	Title	Age	Since
Sung-Ho Ryu CTO	Chief Tech/Sci/R&D Officer	-	01/11/01
Dong-Il Han CEO	Chief Executive Officer	-	01/11/01
Seung-Ki Jang BRD	Director/Board Member	-	01/11/01
Young-Ki Yoon BRD	Director/Board Member	54	01/19/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	16,980,252	11,744,052 ( 69.16 %)	0	69.16 %
Stock B	0	920,000	0	0

Name	Equities	%	Valuation
Dong-Il Han 16.55 %	2,810,000	16.55 %	7 M ₩
Sung-Ho Ryu 6.007 %	1,020,000	6.007 %	2 M ₩
Seung-Ki Jang 6.007 %	1,020,000	6.007 %	2 M ₩
Yoon-dong Kim 1.513 %	256,834	1.513 %	627 659 ₩
Postech Research & Business Development Foundation 0.9423 %	160,000	0.9423 %	391 013 ₩
Jong-ha Jung 0.3534 %	60,000	0.3534 %	146 630 ₩
Aptamer Sciences, Inc. ESOA 0.2391 %	40,600	0.2391 %	99 219 ₩
Dae-gyun Lee 0.1307 %	22,200	0.1307 %	54 253 ₩

Name	Equities	%	Valuation
Postech Research & Business Development Foundation 100.00 %	920,000	100.00 %	2 M ₩

Aptamer Sciences, Inc.

172 Dolma-ro Bundang-gu

13605, Seongnam-si

http://www.aptsci.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
APTAMER SCIENCES INC	-23.16%	34.34M
MODERNA, INC.	+17.96%	44.96B
LONZA GROUP AG	+48.77%	41.85B
IQVIA HOLDINGS INC.	+1.17%	42.65B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+11.42%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.39%	19.03B
BIO-TECHNE CORPORATION	+4.86%	12.75B
MEDPACE HOLDINGS, INC.	+27.29%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.50%	11.75B

Other Biotechnology & Medical Research